New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors

Aristotelis Bamias*, Axel Merseburger, Yohann Loriot, Nicholas James, Ernest Choy, Daniel Castellano, F. Lopez-Rios, Fabio Calabrò, Mario Kramer, Guillermo De Velasco, Roubini Zakopoulou, Kimon Tzannis, Cora N. Sternberg

*Korrespondierende/r Autor/-in für diese Arbeit
5 Zitate (Scopus)

Fingerprint

Untersuchen Sie die Forschungsthemen von „New prognostic model in patients with advanced urothelial carcinoma treated with second-line immune checkpoint inhibitors“. Zusammen bilden sie einen einzigartigen Fingerprint.

Medizin & Biologie